These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1344 related items for PubMed ID: 31383483
21. Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment. Reznicek L, Cserhati S, Seidensticker F, Liegl R, Kampik A, Ulbig M, Neubauer AS, Kernt M. Acta Ophthalmol; 2013 Nov; 91(7):e529-36. PubMed ID: 23647578 [Abstract] [Full Text] [Related]
25. Optical coherence tomography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy. Sorour OA, Sabrosa AS, Yasin Alibhai A, Arya M, Ishibazawa A, Witkin AJ, Baumal CR, Duker JS, Waheed NK. Int Ophthalmol; 2019 Oct; 39(10):2361-2371. PubMed ID: 31119505 [Abstract] [Full Text] [Related]
26. Decrease in the number of microaneurysms in diabetic macular edema after anti-vascular endothelial growth factor therapy: implications for indocyanine green angiography-guided detection of refractory microaneurysms. Mori K, Yoshida S, Kobayashi Y, Ishikawa K, Nakao S, Hisatomi T, Haruta M, Isihibashi T, Sonoda KH. Graefes Arch Clin Exp Ophthalmol; 2020 Apr; 258(4):735-741. PubMed ID: 31960130 [Abstract] [Full Text] [Related]
27. Relationship Between Retinal Fractal Dimension and Nonperfusion in Diabetic Retinopathy on Ultrawide-Field Fluorescein Angiography. Fan W, Nittala MG, Fleming A, Robertson G, Uji A, Wykoff CC, Brown DM, van Hemert J, Ip M, Wang K, Falavarjani KG, Singer M, Sagong M, Sadda SR. Am J Ophthalmol; 2020 Jan; 209():99-106. PubMed ID: 31472160 [Abstract] [Full Text] [Related]
28. Feasibility and Clinical Utility of Wide-Field Optical Coherence Tomography Angiography Compared to Ultrawide-Field Fluorescein Angiography in Patients with Diabetic Retinopathy. Bajka A, Bacci T, Wiest MRJ, Brinkmann M, Hamann T, Toro M, Zweifel SA. Klin Monbl Augenheilkd; 2023 Apr; 240(4):490-495. PubMed ID: 37164407 [Abstract] [Full Text] [Related]
29. Correlation between Diabetic Retinopathy Severity and Oxygen Metabolism in Patients with Diabetic Macular Edema during Treatment with Intravitreal Aflibercept. Blindbæk SL, Peto T, Grauslund J. Ophthalmic Res; 2020 Apr; 63(2):106-113. PubMed ID: 31715608 [Abstract] [Full Text] [Related]
31. Efficacy of Ranibizumab in Eyes with Diabetic Macular Edema and Macular Nonperfusion in RIDE and RISE. Reddy RK, Pieramici DJ, Gune S, Ghanekar A, Lu N, Quezada-Ruiz C, Baumal CR. Ophthalmology; 2018 Oct; 125(10):1568-1574. PubMed ID: 29752001 [Abstract] [Full Text] [Related]
32. Distinguishing Diabetic Macular Edema From Capillary Nonperfusion Using Optical Coherence Tomography Angiography. de Carlo TE, Chin AT, Joseph T, Baumal CR, Witkin AJ, Duker JS, Waheed NK. Ophthalmic Surg Lasers Imaging Retina; 2016 Feb; 47(2):108-14. PubMed ID: 26878442 [Abstract] [Full Text] [Related]
34. Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy. Ip MS, Domalpally A, Sun JK, Ehrlich JS. Ophthalmology; 2015 Feb; 122(2):367-74. PubMed ID: 25439595 [Abstract] [Full Text] [Related]